Cargando…

DNMT3A R882 Mutations Predict a Poor Prognosis in AML: A Meta-Analysis From 4474 Patients

DNA (cytosine-5)-methyltransferase 3 alpha (DNMT3A) mutations were widely believed to be independently associated with inferior prognosis in acute myeloid leukemia (AML) patients. As dominant missense alterations in DNMT3A mutations, R882 mutations cause the focal hypomethylation phenotype. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Xiao-Qing, Peng, Li, Zeng, Wen-Jing, Jiang, Bin-Yuan, Li, Guan-Cheng, Chen, Xiao-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863771/ https://www.ncbi.nlm.nih.gov/pubmed/27149454 http://dx.doi.org/10.1097/MD.0000000000003519

Ejemplares similares

Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2019)

DNMT3A(R882)-associated hypomethylation patterns are maintained in primary AML xenografts, but not in the DNMT3A(R882C) OCI-AML3 leukemia cell line
por: Chen, David, et al.
Publicado: (2018)

DNMT3A mutations in Chinese childhood acute myeloid leukemia
por: Li, Weijing, et al.
Publicado: (2017)

Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations
por: Yang, Li, et al.
Publicado: (2019)

DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation
por: Jawad, Majd, et al.
Publicado: (2022)

The DNMT3A R882H mutation does not cause dominant negative effects in purified mixed DNMT3A/R882H complexes
por: Emperle, Max, et al.
Publicado: (2018)

The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis
por: Yang, Yuan, et al.
Publicado: (2019)

Gene expression profiling of the DNMT3A R882 mutation in acute leukemia
por: HUANG, XIANGNAN, et al.
Publicado: (2013)

Efficacy and safety of selinexor in the treatment of AML: A protocol for systematic review and meta-analysis
por: Yu, Liming, et al.
Publicado: (2021)

Recurrent DNMT3A R882 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Lin, Jiang, et al.
Publicado: (2011)

Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia
por: Berenstein, Rimma, et al.
Publicado: (2015)

Structural basis for impairment of DNA methylation by the DNMT3A R882H mutation
por: Anteneh, Hiwot, et al.
Publicado: (2020)

Clinical features and outcomes of hypocellular acute myeloid leukemia in adults: A Korean AML registry data
por: Song, Ik-Chan, et al.
Publicado: (2021)

AML, ALL, and CML classification and diagnosis based on bone marrow cell morphology combined with convolutional neural network: A STARD compliant diagnosis research
por: Huang, Furong, et al.
Publicado: (2020)

Recombinant human thrombopoietin promotes platelet recovery in DCAG-treated patients with intermediate-high-risk MDS/hypoproliferative AML
por: Chen, Xiangli, et al.
Publicado: (2023)

Clinical prognosis and bioinformatic analysis of primary thyroid lymphoma
por: Bai, Zhimin, et al.
Publicado: (2021)

Effect of enhancer of zeste homolog 2 mutations on the prognosis of patients with myelodysplastic syndrome: A meta-analysis
por: Huang, Xinyue, et al.
Publicado: (2020)

An acquired BMF with FANCL gene heterozygous mutation: Case report
por: Zhang, Nan, et al.
Publicado: (2023)

Oridonin inhibits DNMT3A R882 mutation-driven clonal hematopoiesis and leukemia by inducing apoptosis and necroptosis
por: Liao, Min, et al.
Publicado: (2021)

Gene mutations in the PI3K/Akt signaling pathway were related to immune thrombocytopenia pathogenesis
por: Ruan, Jing-Shu, et al.
Publicado: (2023)

Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENs
por: Yang, Li, et al.
Publicado: (2017)

The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis
por: Ruan, Xiao-Lan, et al.
Publicado: (2015)

Inherited antithrombin deficiency caused by a mutation in the SERPINC1 gene: A case report
por: Hou, Xinwei, et al.
Publicado: (2022)

Case report: Successful treatment of Chidamide in a refractory/recurrent SPTCL with ARID1A mutation on the basis of CHOP plus auto-HSCT
por: Zhang, Nan, et al.
Publicado: (2023)

Bortezomib-based regimens improve the prognosis of newly diagnosed MM patients with chromosomal aberrations except for del(17q13): A retrospective study from a single center
por: Liu, Zhigang, et al.
Publicado: (2021)

Mutations of R882 change flanking sequence preferences of the DNA methyltransferase DNMT3A and cellular methylation patterns
por: Emperle, Max, et al.
Publicado: (2019)

The DNMT3A R882H mutant displays altered flanking sequence preferences
por: Emperle, Max, et al.
Publicado: (2018)

Impact of iron overload on poor graft function after allo-HSCT in a patient with transfusion-dependent low-risk MDS: A case report and literature review
por: Wang, Cong, et al.
Publicado: (2022)

Severe malnutrition evaluated by patient-generated subjective global assessment results in poor outcome among adult patients with acute leukemia: A retrospective cohort study
por: Li, Ji, et al.
Publicado: (2018)

Clinical efficacy and safety of imatinib treatment in children and adolescents with chronic myeloid leukemia: A single-center experience in China
por: Deng, Mengyue, et al.
Publicado: (2020)

Prognostic significance of latent membrane protein 1 expression in non-Hodgkin lymphoma: A meta-analysis
por: Li, Xiao-Mei, et al.
Publicado: (2017)

Efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating non-Hodgkin lymphoma: A systematic review and meta-analysis of clinical trials
por: Guan, Jiaheng, et al.
Publicado: (2022)

IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era
por: Chen, Xiangli, et al.
Publicado: (2020)

A case report of lineage switch from T-cell acute leukemia to B-cell acute leukemia
por: Zhu, Yejing, et al.
Publicado: (2020)

Anti-CD19 chimeric antigen receptor T-cell therapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia: Two case reports
por: Zhu, Yang-min, et al.
Publicado: (2016)

Immune thrombocytopenia associated with Hashimoto thyroiditis in a pediatric patient: A case report
por: Tian, Zhiqing, et al.
Publicado: (2021)

Familial hemophagocytic lymphohistiocytosis type 5 in a Chinese Tibetan patient caused by a novel compound heterozygous mutation in STXBP2
por: Tang, Xue, et al.
Publicado: (2019)

Relapsed/refractory acute promyelocytic leukemia with RARA-LBD region mutation was salvaged by venetoclax: A case report
por: Li, Youli, et al.
Publicado: (2021)

Successful treatment with matched unrelated donor peripheral blood stem cell transplantation for very severe aplastic anemia in presence of active infections: A case report
por: Huang, Yu-Rong, et al.
Publicado: (2020)

Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7tl7h0on0u77qr6la2iev2ep27